Literature DB >> 29757600

DARK Classics in Chemical Neuroscience: Morphine.

Andrea L Devereaux1, Susan L Mercer2, Christopher W Cunningham1.   

Abstract

As the major psychoactive agent in opium and direct precursor for heroin, morphine is a historically critical molecule in chemical neuroscience. A structurally complex phenanthrene alkaloid produced by Papaver somniferum, morphine has fascinated chemists seeking to disentangle pharmacologically beneficial analgesic effects from addiction, tolerance, and dependence liabilities. In this review, we will detail the history of morphine, from the first extraction and isolation by Sertürner in 1804 to the illicit use of morphine and proliferation of opioid use and abuse disorders currently ravaging the United States. Morphine is a molecule of great cultural relevance, as the agent that single-handedly transformed our understanding of pharmacognosy, receptor dynamics, and substance abuse and dependence disorders.

Entities:  

Keywords:  Morphine; analgesics; dependence; mu opioid receptor; opium; tolerance

Mesh:

Substances:

Year:  2018        PMID: 29757600     DOI: 10.1021/acschemneuro.8b00150

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  13 in total

1.  Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.

Authors:  Anthony F Nastase; Jessica P Anand; Aaron M Bender; Deanna Montgomery; Nicholas W Griggs; Thomas J Fernandez; Emily M Jutkiewicz; John R Traynor; Henry I Mosberg
Journal:  J Med Chem       Date:  2019-04-09       Impact factor: 7.446

Review 2.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

3.  The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain.

Authors:  Huanbai Wang; Xiaodan Li; Dongting Zhangsun; Gang Yu; Ruibin Su; Sulan Luo
Journal:  Mar Drugs       Date:  2019-05-05       Impact factor: 5.118

4.  Poppy Seed Tea: A Short Review and Case Study.

Authors:  Irving Haber; Joseph Pergolizzi; Jo Ann LeQuang
Journal:  Pain Ther       Date:  2019-02-05

Review 5.  Advances in the Physicochemical Profiling of Opioid Compounds of Therapeutic Interest.

Authors:  Károly Mazák; Béla Noszál; Sándor Hosztafi
Journal:  ChemistryOpen       Date:  2019-07-04       Impact factor: 2.911

6.  Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2].

Authors:  Zhiguo Li; Xiaolu Han; Xiaoxuan Hong; Xianfu Li; Jing Gao; Hui Zhang; Aiping Zheng
Journal:  Mar Drugs       Date:  2021-02-25       Impact factor: 5.118

Review 7.  Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs.

Authors:  Sharna-Kay Daley; Geoffrey A Cordell
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

8.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

Review 9.  Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones.

Authors:  Mariana Spetea; Helmut Schmidhammer
Journal:  Molecules       Date:  2021-09-18       Impact factor: 4.411

10.  Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists.

Authors:  Teresa Kaserer; Theresa Steinacher; Roman Kainhofer; Filippo Erli; Sonja Sturm; Birgit Waltenberger; Daniela Schuster; Mariana Spetea
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.